UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 173

Sortiert nach

Mechanisms of Resistance to Conventional Therapies for Osteosarcoma

Cancers, 2021-02, Vol.13 (4), p.683

2021

Link zum Volltext

Verfügbarkeit prüfen

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis

International journal of molecular sciences, 2016-12, Vol.17 (12), p.2142-2142

2016

Link zum Volltext

Verfügbarkeit prüfen

Suppression of Heat Shock Protein 27 Using OGX-427 Induces Endoplasmic Reticulum Stress and Potentiates Heat Shock Protein 90 Inhibitors to Delay Castrate-resistant Prostate Cancer

European urology, 2014-07, Vol.66 (1), p.145-155

2014

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma : Blockade of the vicious cycle between tumor cell proliferation and bone resorption

Cancer research (Chicago, Ill.), 2007-08, Vol.67 (15), p.7308-7318

2007

Link zum Volltext

Verfügbarkeit prüfen

Implication of molecular vascular smooth muscle cell heterogeneity among arterial beds in arterial calcification

PloS one, 2018-01, Vol.13 (1), p.e0191976-e0191976

2018

Link zum Volltext

Verfügbarkeit prüfen

Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle

Nature communications, 2014-03, Vol.5 (1), p.3511-3511, Article 3511

2014

Link zum Volltext

Verfügbarkeit prüfen

Development of prohibitin ligands against osteoporosis

European journal of medicinal chemistry, 2021-01, Vol.210, p.112961-112961, Article 112961

2021

Link zum Volltext

Verfügbarkeit prüfen

Osteoprotegerin: Multiple partners for multiple functions

Cytokine & growth factor reviews, 2013-10, Vol.24 (5), p.401-409

2013

Link zum Volltext

Verfügbarkeit prüfen

Ribosomopathies: New Therapeutic Perspectives

Cells (Basel, Switzerland), 2020-09, Vol.9 (9), p.2080

2020

Link zum Volltext

Verfügbarkeit prüfen

Tracking Targets of Dynamic Super-Enhancers in Vitro to Better Characterize Osteoclastogenesis and to Evaluate the Effect of Diuron on the Maturation of Human Bone Cells

Environmental health perspectives, 2023-06, Vol.131 (6), p.67007-67007

2023

Link zum Volltext

Verfügbarkeit prüfen

The p53 Family Members p63 and p73 Roles in the Metastatic Dissemination: Interactions with microRNAs and TGFβ Pathway

Cancers, 2022-12, Vol.14 (23), p.5948

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues

Cells (Basel, Switzerland), 2021-03, Vol.10 (4), p.754

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1

Oncotarget, 2016-04, Vol.7 (17), p.24125-24140

2016

Link zum Volltext

Verfügbarkeit prüfen

BYL719, a new α‐specific PI3K inhibitor: Single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma

International journal of cancer, 2015-02, Vol.136 (4), p.784-796

2015

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of BET proteins and epigenetic signaling as a potential treatment for osteoporosis

Bone (New York, N.Y.), 2017-01, Vol.94, p.10-21

2017

Link zum Volltext

Verfügbarkeit prüfen

Super-enhancers: drivers of cells’ identities and cells’ debacles

Epigenomics, 2024-04, Vol.16 (9), p.681-700

2024

Link zum Volltext

Verfügbarkeit prüfen

Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients

Cancer research (Chicago, Ill.), 2010-10, Vol.70 (19), p.7610-7619

2010

Link zum Volltext

Verfügbarkeit prüfen

miRNA-193a-5p repression of p73 controls Cisplatin chemoresistance in primary bone tumors

Oncotarget, 2016-08, Vol.7 (34), p.54503-54514

2016

Link zum Volltext

Verfügbarkeit prüfen

BET bromodomains’ functions in bone-related pathologies

Epigenomics, 2020-01, Vol.12 (2), p.127-144

2020

Link zum Volltext

Verfügbarkeit prüfen

ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis

Cancer research (Chicago, Ill.), 2016-06, Vol.76 (11), p.3236-3251

2016

Link zum Volltext

Verfügbarkeit prüfen

Proteoglycans: key partners in bone cell biology

BioEssays, 2007-08, Vol.29 (8), p.758-771

2007

Link zum Volltext

Verfügbarkeit prüfen

The Eye of the Master: Figures of the Québécois Colonial Imaginary . Dalie Giroux

The Canadian historical review, 2024-03, Vol.105 (1), p.153-154

Lamoureux, François

2024

Link zum Volltext

Verfügbarkeit prüfen

Sonic Hedgehog Signature in Pediatric Primary Bone Tumors: Effects of the GLI Antagonist GANT61 on Ewing’s Sarcoma Tumor Growth

Cancers, 2020-11, Vol.12 (11), p.3438

2020

Link zum Volltext

Verfügbarkeit prüfen

Implication of the p53-Related miR-34c, -125b, and -203 in the Osteoblastic Differentiation and the Malignant Transformation of Bone Sarcomas

Cells (Basel, Switzerland), 2020-03, Vol.9 (4), p.810

2020

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619

Cells (Basel, Switzerland), 2021-08, Vol.10 (9), p.2268

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 173

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(151)
Mit Volltextzugriff
(155)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Mechanisms of Resistance to Conventional Therapies for Osteosarcoma

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis

Suppression of Heat Shock Protein 27 Using OGX-427 Induces Endoplasmic Reticulum Stress and Potentiates Heat Shock Protein 90 Inhibitors to Delay Castrate-resistant Prostate Cancer

Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma : Blockade of the vicious cycle between tumor cell proliferation and bone resorption

Implication of molecular vascular smooth muscle cell heterogeneity among arterial beds in arterial calcification

Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle

Development of prohibitin ligands against osteoporosis

Osteoprotegerin: Multiple partners for multiple functions

Ribosomopathies: New Therapeutic Perspectives

Tracking Targets of Dynamic Super-Enhancers in Vitro to Better Characterize Osteoclastogenesis and to Evaluate the Effect of Diuron on the Maturation of Human Bone Cells

The p53 Family Members p63 and p73 Roles in the Metastatic Dissemination: Interactions with microRNAs and TGFβ Pathway

Molecular Chaperones in Osteosarcoma: Diagnosis and Therapeutic Issues

Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1

BYL719, a new α‐specific PI3K inhibitor: Single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma

Inhibition of BET proteins and epigenetic signaling as a potential treatment for osteoporosis

Super-enhancers: drivers of cells’ identities and cells’ debacles

Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients

miRNA-193a-5p repression of p73 controls Cisplatin chemoresistance in primary bone tumors

BET bromodomains’ functions in bone-related pathologies

ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis

Proteoglycans: key partners in bone cell biology

The Eye of the Master: Figures of the Québécois Colonial Imaginary . Dalie Giroux

Sonic Hedgehog Signature in Pediatric Primary Bone Tumors: Effects of the GLI Antagonist GANT61 on Ewing’s Sarcoma Tumor Growth

Implication of the p53-Related miR-34c, -125b, and -203 in the Osteoblastic Differentiation and the Malignant Transformation of Bone Sarcomas

Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619

Suchergebnisse filtern